awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52661781-4E9681FF-93C1-4597-B87C-208F2D18121C
Q52661781-4E9681FF-93C1-4597-B87C-208F2D18121C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52661781-4E9681FF-93C1-4597-B87C-208F2D18121C
Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion.
P2860
Q52661781-4E9681FF-93C1-4597-B87C-208F2D18121C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52661781-4E9681FF-93C1-4597-B87C-208F2D18121C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cff4901241a6ef1d95e898f12ff5a9ef4310e613
P2860
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer